Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
8
×
biotech
clinical trials
boston blog main
europe blog main
national
san francisco blog main
brexit
drugs
europe
falsified medicines
fda
innovation
labeling
mhra
regulations
san francisco top stories
uk
akouos
boston
cancer
deals
national top stories
raleigh-durham blog main
raleigh-durham top stories
abbvie
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
andrew berens
anirvan ghosh
aspire capital fund
astellas pharmaceuticals
astrazeneca
auris health
avapritinib
biogen
blueprint medicines
What
plans
8
×
medicines
end
announced
brexit
charting
choppy
course
dynamic
fda
period
post
regulation
regulatory
reveals
transition
uk
cancer
company
developing
drug
ipo
medicine
acquisitions
affects
americans
approval
approved
area
based
bay
bio
biopsy
blood
blueprint
buildout
cash
ceo
chasing
clearance
Language
unset
8
×
Current search:
unset
×
" national blog main "
×
plans
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
UK Reveals Plans For ‘Dynamic’ Post-Brexit Regulatory System
@xconomy.com
4 years ago
UK Reveals Plans For ‘Dynamic’ Post-Brexit Regulatory System
@xconomy.com
4 years ago
UK Reveals Plans For ‘Dynamic’ Post-Brexit Regulatory System
@xconomy.com
4 years ago
Titan Medical’s Cash Crunch Stalls Plans to Get Surgical Robot to FDA
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug